Literature DB >> 7037384

In vitro immunotoxicological assays for detection of compounds requiring metabolic activation.

A N Tucker, V M Sanders, P Hallett, B M Kauffmann, A E Munson.   

Abstract

A system for metabolic activation of cyclophosphamide (CP), consisting of a crude microsomal fraction of mouse liver and necessary cofactors (S9 mix), was interfaced with three murine cell culture assays for immunotoxicity. These assays were: the Mishell-Dutton assay for in vitro antibody formation, splenic lymphocyte responsiveness to mitogens and bone marrow cell cultures. There was no effect of CP at doses up to 261 microgram/ml (lmM) on any of the parameters measured unless S9 mix was included. Much greater potency was achieved if the S9 mix was prepared from livers of mice pretreated with phenobarbital. Under these conditions and dose-related inhibition of plaque-forming cells (PFC) in the Mishell-Dutton assay was observed, yielding an ED50 of 6.3 microgram/ml. When splenic lymphocytes were exposed to CP in the presence of induced S9 mix, a dose related inhibition of the response to the B-cell mitogen, lipopolysaccharide (LPS), and to the T-cell mitogen, concanavalin A (Con A), was observed. For the optimum LPS concentration, the ED50 for CP was 8.1 microgram/ml; for the optimum concentration of Con A, the ED50 was 6.7 microgram/ml. DNA synthesis was not inhibited by the doses used. When bone marrow cells were exposed to CP in the presence of induced S9 mix, the stem cell population, enumerated by colonization in semisolid medium, was reduced in a dose-dependent manner, with an ED50 of 5.2 microgram/ml. Again, DNA synthesis was not affected unless higher doses of CP were used.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7037384      PMCID: PMC1568891          DOI: 10.1289/ehp.8243123

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  10 in total

1.  Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.

Authors:  J McCann; E Choi; E Yamasaki; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

2.  Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide.

Authors:  T A Connors; P J Cox; P B Farmer; A B Foster; M Jarman
Journal:  Biochem Pharmacol       Date:  1974-01-01       Impact factor: 5.858

3.  Further improvements in the plaque technique for detecting single antibody-forming cells.

Authors:  A J Cunningham; A Szenberg
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

4.  Evaluation of chemicals for immunomodulatory effects using an in vitro antibody-producing assay.

Authors:  S A Kutz; R D Hinsdill; D J Weltman
Journal:  Environ Res       Date:  1980-08       Impact factor: 6.498

5.  Assessment of immunobiological effects induced by chemicals, drugs or food additives. II. Studies with cyclophosphamide.

Authors:  J H Dean; M L Padarathsingh; T R Jerrells; L Keys; J W Northing
Journal:  Drug Chem Toxicol       Date:  1979       Impact factor: 3.356

6.  Sister chromatid exchange as an assay for genetic damage induced by mutagen-carcinogens. II. In vitro test for compounds requiring metabolic activation.

Authors:  D G Stetka; S Wolff
Journal:  Mutat Res       Date:  1976-12       Impact factor: 2.433

7.  In vitro inhibition of the primary antibody response to sheep erythrocytes by cyclophosphamide.

Authors:  A N Tucker; A E Munson
Journal:  Toxicol Appl Pharmacol       Date:  1981-07       Impact factor: 4.219

8.  Teratogenic bioactivation of cyclophosphamide in vitro.

Authors:  A G Fantel; J C Greenaway; M R Juchau; T H Shepard
Journal:  Life Sci       Date:  1979-07-02       Impact factor: 5.037

9.  Use of an in vitro antibody-producing system for recognizing potentially immunosuppressive compounds.

Authors:  D L Archer; B G Smith; J A Bukovic-Wess
Journal:  Int Arch Allergy Appl Immunol       Date:  1978

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

  10 in total
  1 in total

1.  New approaches to immunotoxicity testing.

Authors:  D L Archer
Journal:  Environ Health Perspect       Date:  1982-02       Impact factor: 9.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.